Z

Zenas Biopharma Inc
NASDAQ:ZBIO

Watchlist Manager
Zenas Biopharma Inc
NASDAQ:ZBIO
Watchlist
Price: 18.94 USD -2.67% Market Closed
Market Cap: 797.6m USD

Wall Street
Price Targets

ZBIO Price Targets Summary
Zenas Biopharma Inc

Wall Street analysts forecast ZBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZBIO is 33.08 USD with a low forecast of 24.24 USD and a high forecast of 47.25 USD.

Lowest
Price Target
24.24 USD
28% Upside
Average
Price Target
33.08 USD
75% Upside
Highest
Price Target
47.25 USD
149% Upside
Zenas Biopharma Inc Competitors:
Price Targets
CPRX
Catalyst Pharmaceuticals Inc
75% Upside
005690
Pharmicell Co Ltd
35% Upside
ANVS
Annovis Bio Inc
505% Upside
KURN
Kuros Biosciences AG
39% Upside
GNS
Genus PLC
16% Upside
ALNY
Alnylam Pharmaceuticals Inc
2% Downside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
7% Downside
GOSS
Gossamer Bio Inc
196% Upside

Revenue
Forecast

Revenue Estimate
Zenas Biopharma Inc

For the last 1 year the compound annual growth rate for Zenas Biopharma Inc's revenue is -90%. The projected CAGR for the next 3 years is 111%.

-90%
Past Growth
111%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Zenas Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Zenas Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZBIO's stock price target?
Price Target
33.08 USD

According to Wall Street analysts, the average 1-year price target for ZBIO is 33.08 USD with a low forecast of 24.24 USD and a high forecast of 47.25 USD.

What is Zenas Biopharma Inc's Revenue forecast?
Projected CAGR
111%

For the last 1 year the compound annual growth rate for Zenas Biopharma Inc's revenue is -90%. The projected CAGR for the next 3 years is 111%.

Back to Top